CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
8.96
+0.19 (2.17%)
At close: Jun 11, 2026, 4:00 PM EDT
8.98
+0.02 (0.21%)
After-hours: Jun 11, 2026, 7:59 PM EDT

CorMedix Stock Forecast

Stock Price Forecast

According to 6 analysts polled by S&P Global, CorMedix stock has a consensus rating of "Buy" and an average price target of $15.33. The average 1-year stock price forecast is 71.09% higher than the current stock price, while the lowest is $13 (+45.09%) and the highest is $19 (+112.05%).

Price Target: $15.33 (+71.09%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$13$15.33$15$19
Change+45.09%+71.09%+67.41%+112.05%

Analyst Ratings

The average analyst rating for CorMedix stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingDec '25Jan '26Feb '26Mar '26Apr '26May '26
Strong Buy444443
Buy333333
Hold000000
Sell000000
Strong Sell000000
Total777776

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Leerink Partners
Leerink Partners
Buy
Reiterates
$14$15
BuyReiterates$14$15+67.41%May 15, 2026
Truist Financial
Truist Financial
Buy
Maintains
n/a
BuyMaintainsn/an/aMay 15, 2026
RBC Capital
RBC Capital
Buy
Reiterates
$14
BuyReiterates$14+56.25%May 15, 2026
Needham
Needham
Buy
Maintains
$15
BuyMaintains$15+67.41%May 14, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$13
BuyReiterates$13+45.09%May 14, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
332.71M
from 311.71M
Increased by 6.74%
Revenue Next Year
286.79M
from 332.71M
Decreased by -13.80%
EPS This Year
0.97
from 2.15
Decreased by -54.80%
EPS Next Year
0.35
from 0.97
Decreased by -63.92%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
190.94K65.41K-43.47M311.71M332.71M
Revenue Growth
-20.19%-65.74%--617.03%6.74%
Gross Profit
42.00K61.67K-40.44M289.62M260.51M
Gross Margin
22.00%94.29%-93.02%92.91%78.30%
Operating Income
-29.44M-30.62M-48.96M-22.36M160.34M80.01M
Net Income
-28.21M-29.70M-46.34M-17.93M163.06M47.13M
EPS
----2.150.97
EPS Growth
------54.80%
Forward PE
---12.274.159.24
Free Cash Flow
-12.73M-14.03M-22.97M-44.72M108.51M92.86M
No. Analysts
-----6
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High336.0M
Avg332.7M
Low325.8M

Revenue Growth

Revenue Growth202620272028
High
7.8%
Avg
6.7%
Low
4.5%

EPS Forecast

EPS202620272028
High-
Avg0.97
Low-

EPS Growth

EPS Growth202620272028
High-
Avg
-54.8%
Low-